Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interpretation of resistance data from randomized trials of first-line antiretroviral treatment.

AIDS reviews - 1 Jan 2000

Clotet Bonaventura, Hill Andrew, van Delft Yvon, Gupta Ravindra Kumar, Moecklinghoff Christiane

Abstract excerpt

There are four key differences between HIV clinical trials in the analysis of HIV drug resistance: (i) baseline resistance testing used versus not used for patient inclusion; (ii) using HIV RNA cutoff levels of ≥ 50 versus ≥ 400 copies/ml to define virologic failure; (iii) testing versus not test...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alkynes
Share to Anti-HIV Agents
Share to Benzoxazines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD4 Lymphocyte Count

Share to Cyclopropanes

Share to Randomized Controlled Trials as Topic

Share to Reverse Transcriptase Inhibitors

Share to Viral Load

Source

Identifiers

PMID: 23258299

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23258299-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interpretation of resistance data from randomized trials of first-line antiretroviral treatment.PMID 23258299Read ↗

Emergence of HIV drug resistance during first- and second-line antiretroviral therapy in resource-limited settings.Semantic proximity Read ↗

First line treatment response in patients with transmitted HIV drug resistance and well defined time point of HIV infection: updated results from the German HIV-1 seroconverter study.Semantic proximity Read ↗

Characterization of HIV-1 drug resistance development through week 48 in antiretroviral naive subjects on rilpivirine/emtricitabine/tenofovir DF or efavirenz/emtricitabine/tenofovir DF in the STaR study (GS-US-264-0110).Semantic proximity Read ↗

HIV-1 drug resistance in subjects with advanced HIV-1 infection in whom antiretroviral combination therapy is failing: a substudy of AIDS Clinical Trials Group Protocol 388.Semantic proximity Read ↗

96-week resistance analyses of the STaR study: rilpivirine/emtricitabine/tenofovir DF versus efavirenz/emtricitabine/tenofovir DF in antiretroviral-naive, HIV-1-infected subjects.Semantic proximity Read ↗

The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan.Semantic proximity Read ↗

Low-frequency nevirapine (NVP)-resistant HIV-1 variants are not associated with failure of antiretroviral therapy in women without prior exposure to single-dose NVP.Semantic proximity Read ↗

Extent of human immunodeficiency virus type 1 drug resistance as a predictor of virological failure after genotype-guided treatment switch.Semantic proximity Read ↗

Baseline genotype as a predictor of virological failure to emtricitabine or stavudine in combination with didanosine and efavirenz.Semantic proximity Read ↗

Resistance and virological response analyses in a three initial treatment strategy trial: a substudy of the INITIO trial.Semantic proximity Read ↗

Clinical Outcomes of Virologically-Suppressed Patients with Pre-existing HIV-1 Drug Resistance Mutations Switching to Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in the SPIRIT Study.Semantic proximity Read ↗

Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.